Evaluation of Fibroblast Activation Protein Expression Using<sup>68</sup>Ga-FAPI46 PET in Hypertension-Induced Tissue Changes

Chronic hypertension leads to injury and fibrosis in major organs. Fibroblast activation protein (FAP) is one of key molecules in tissue fibrosis, and <sup>68</sup>Ga-labeled FAP inhibitor-46 (FAPI46) PET is a recently developed method for evaluating FAP. The aim of this study was to evaluate FAP expression and fibrosis in a hypertension model and to test the feasibility of <sup>68</sup>Ga-FAPI46 PET in hypertension. <b>Methods:</b> Hypertension was induced in mice by angiotensin II infusion for 4 wk. <sup>68</sup>Ga-FAPI46 biodistribution studies and PET scanning were conducted at 1, 2, and 4 wk after hypertension modeling, and uptake in the major organs was measured. The FAP expression and fibrosis formation of the heart and kidney tissues were analyzed and compared with <sup>68</sup>Ga-FAPI46 uptake. Subgroups of the hypertension model underwent angiotensin receptor blocker administration and high-dose FAPI46 blocking, for comparison. As a preliminary human study, <sup>68</sup>Ga-FAPI46 PET images of lung cancer patients were analyzed and compared between hypertension and control groups. <b>Results:</b> Uptake of <sup>68</sup>Ga-FAPI46 in the heart and kidneys was significantly higher in the hypertension group than in the sham group as early as week 1 and decreased after week 2. The uptake was specifically blocked in the high-dose blocking study. Immunohistochemistry also revealed FAP expression in both heart and kidney tissues. However, overt fibrosis was observed in the heart, whereas it was absent from the kidneys. The angiotensin receptor blocker-treated group showed lower uptake in the heart and kidneys than did the hypertension group. In the pilot human study, renal uptake of <sup>68</sup>Ga-FAPI46 significantly differed between the hypertension and control groups. <b>Conclusion:</b> In hypertension, FAP expression is increased in the heart and kidneys from the early phases and decreases over time. FAP expression appears to represent fibrosis activity preceding or underlying fibrotic tissue formation. <sup>68</sup>Ga-FAPI46 PET has potential as an effective imaging method for evaluating FAP expression in progressive fibrosis by hypertension.

Authors

Institutions

Publication Details

Journal
Journal of Nuclear Medicine
Published
2024-09-26
DOI
https://doi.org/10.2967/jnumed.124.267489
Citations
5
Primary Topic
Peptidase Inhibition and Analysis
Type
article
Field-Weighted Citation Impact
1.41
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of Fibroblast Activation Protein Expression Using68Ga-FAPI46 PET in Hypertension-Induced Tissue Changes

Gi Jeong Cheon, Seung‐Pyo Lee, Keon Wook Kang, Jung Woo Byun et al.
5 citations
Journal of Nuclear Medicine
Peptidase Inhibition and Analysis
1.41
article

Evaluation of Fibroblast Activation Protein Expression Using68Ga-FAPI46 PET in Hypertension-Induced Tissue Changes

Gi Jeong Cheon, Seung‐Pyo Lee, Keon Wook Kang, Jung Woo Byun, Yun‐Sang Lee, Young Ju Kim, Hongyoon Choi, Jin Chul Paeng
article en
5 citations

Abstract

Chronic hypertension leads to injury and fibrosis in major organs. Fibroblast activation protein (FAP) is one of key molecules in tissue fibrosis, and <sup>68</sup>Ga-labeled FAP inhibitor-46 (FAPI46) PET is a recently developed method for evaluating FAP. The aim of this study was to evaluate FAP expression and fibrosis in a hypertension model and to test the feasibility of <sup>68</sup>Ga-FAPI46 PET in hypertension. <b>Methods:</b> Hypertension was induced in mice by angiotensin II infusion for 4 wk. <sup>68</sup>Ga-FAPI46 biodistribution studies and PET scanning were conducted at 1, 2, and 4 wk after hypertension modeling, and uptake in the major organs was measured. The FAP expression and fibrosis formation of the heart and kidney tissues were analyzed and compared with <sup>68</sup>Ga-FAPI46 uptake. Subgroups of the hypertension model underwent angiotensin receptor blocker administration and high-dose FAPI46 blocking, for comparison. As a preliminary human study, <sup>68</sup>Ga-FAPI46 PET images of lung cancer patients were analyzed and compared between hypertension and control groups. <b>Results:</b> Uptake of <sup>68</sup>Ga-FAPI46 in the heart and kidneys was significantly higher in the hypertension group than in the sham group as early as week 1 and decreased after week 2. The uptake was specifically blocked in the high-dose blocking study. Immunohistochemistry also revealed FAP expression in both heart and kidney tissues. However, overt fibrosis was observed in the heart, whereas it was absent from the kidneys. The angiotensin receptor blocker-treated group showed lower uptake in the heart and kidneys than did the hypertension group. In the pilot human study, renal uptake of <sup>68</sup>Ga-FAPI46 significantly differed between the hypertension and control groups. <b>Conclusion:</b> In hypertension, FAP expression is increased in the heart and kidneys from the early phases and decreases over time. FAP expression appears to represent fibrosis activity preceding or underlying fibrotic tissue formation. <sup>68</sup>Ga-FAPI46 PET has potential as an effective imaging method for evaluating FAP expression in progressive fibrosis by hypertension.

Journal of Nuclear MedicineVol. 65(11)
Seoul National University (KR), Seoul National University Hospital (KR), National University College (PR)
Zero hunger
Openalex Percentile: Top 15%
Peptidase Inhibition and Analysis
1.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.